0001123292-17-000397.txt : 20170214
0001123292-17-000397.hdr.sgml : 20170214
20170214160435
ACCESSION NUMBER: 0001123292-17-000397
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170210
FILED AS OF DATE: 20170214
DATE AS OF CHANGE: 20170214
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO
CENTRAL INDEX KEY: 0000021665
STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
IRS NUMBER: 131815595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 2123102000
MAIL ADDRESS:
STREET 1: 300 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUSTON JOHN J
CENTRAL INDEX KEY: 0001227249
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00644
FILM NUMBER: 17608573
MAIL ADDRESS:
STREET 1: C/O COLGATE PALMOLIVE CO
STREET 2: 300 PARK AVE 15TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-02-10
0000021665
COLGATE PALMOLIVE CO
CL
0001227249
HUSTON JOHN J
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
NEW YORK
NY
10022
0
1
0
0
SVP, Chief of Staff
Common Stock
2017-02-10
4
M
0
14000
45.23
A
102718
D
Common Stock
2017-02-10
4
S
0
14000
66.6428
D
88718
D
Common Stock
34991
I
By Issuer's 401(k) Plan Trustee
Stock Option (Right to Buy)
45.23
2017-02-10
4
M
0
14000
0
D
2017-09-07
Common Stock
14000
28000
D
Exercise of stock options awarded under the issuer's employee stock option plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's employee stock option plan and the related tax withholding. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Weighted average price, as these shares were sold in multiple transactions at prices ranging from $66.47 to $66.77, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2011 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact
2017-02-14